Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia‐Induced Vulnerabilities in Multiple Myeloma

ABSTRACT Background Multiple myeloma (MM) is a blood cancer marked by the abnormal clonal growth of plasma cells. Hypoxia plays a critical role in the progression and treatment resistance of MM. Aims This study investigates the expression of B‐cell/CLL lymphoma 2 (BCL2) family genes. We also investi...

全面介紹

Saved in:
書目詳細資料
Main Authors: Seiichi Okabe, Yuya Arai, Yuko Tanaka, Akihiko Gotoh
格式: Article
語言:英语
出版: Wiley 2025-06-01
叢編:Cancer Reports
主題:
在線閱讀:https://doi.org/10.1002/cnr2.70249
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!